Each case study showcases how we deliver impactful, tailored solutions.
Rapid initiation and agile delivery of a complex Phase I COVID vaccine study
This successful trial was completed when the milestone of database lock was achieved just four weeks after last patient last visit.
Global real-world evidence (RWE) pilot study in antimicrobial resistance (AMR)
8,060 hospitalised patient records were submitted — 7,444 (92%) were complete enough to include in the final analysis.
Open-access portal for a global antimicrobial resistance (AMR) surveillance programme
8+ million records across 900,000+ clinical isolates — searchable by pathogen, antimicrobial, demographics, phenotype and genotype.
Phase IIb/c trial of a novel anti-tuberculosis oral regimen completed within one year
Recruitment of patients with tuberculosis can be challenging, and retaining participation of the full quota of 122 patients to assess response to treatment was crucial to the trial’s success.